Inkjet Printing of Pharmaceuticals
Advanced Materials · 2024-03 · 36 (11)
DOI: 10.1002/adma.202309164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 12.12.2023. Verfasst von Paola Carou-Senra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) a…. Hauptthemen laut MEDLINE: Artificial Intelligence, Technology, Pharmaceutical. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Regional Development Fund, Xunta de Galicia, Ministerio de Universidades.
Abstract (Originalsprache)
Inkjet printing (IJP) is an additive manufacturing process that selectively deposits ink materials, layer‐by‐layer, to create 3D objects or 2D patterns with precise control over their structure and composition. This technology has emerged as an attractive and versatile approach to address the ever‐evolving demands of personalized medicine in the healthcare industry. Although originally developed for nonhealthcare applications, IJP harnesses the potential of pharma‐inks, which are meticulously formulated inks containing drugs and pharmaceutical excipients. Delving into the formulation and components of pharma‐inks, the key to precise and adaptable material deposition enabled by IJP is unraveled. The review extends its focus to substrate materials, including paper, films, foams, lenses, and 3D‐printed materials, showcasing their diverse advantages, while exploring a wide spectrum of therapeutic applications. Additionally, the potential benefits of hardware and software improvements, along with artificial intelligence integration, are discussed to enhance IJP's precision and efficiency. Embracing these advancements, IJP holds immense potential to reshape traditional medicine manufacturing processes, ushering in an era of medical precision. However, further exploration and optimization are needed to fully utilize IJP's healthcare capabilities. As researchers push the boundaries of IJP, the vision of patient‐specific treatment is on the horizon of becoming a tangible reality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Univers…
- Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, College Lane, Hatfield, AL10 9AB, UK.
- Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK.
- FABRX Ltd., Henwood House, Henwood, Ashford, Kent, TN24 8DH, UK.
- FABRX Artificial Intelligence, Carretera de Escairón 14, Currelos (O Saviñao), CP 27543, Spain.
ORCID-Profile: Paola Carou-Senra, Lucía Rodríguez-Pombo, Atheer Awad, Abdul W Basit, Carmen Alvarez-Lorenzo, Alvaro Goyanes
Förderung
- European Regional Development Fund
- Xunta de Galicia
- Ministerio de Universidades
- Fundación Mutua Madrileña
- Ministerio de Ciencia e Innovación
Zitieren
APA
Carou-Senra, P., Rodríguez-Pombo, L., Awad, A., Basit, A. W., Alvarez-Lorenzo, C., & Goyanes, A. (2024). Inkjet Printing of Pharmaceuticals. Advanced Materials, 36(11). https://doi.org/10.1002/adma.202309164
Vancouver
Carou-Senra P, Rodríguez-Pombo L, Awad A, Basit AW, Alvarez-Lorenzo C, Goyanes A. Inkjet Printing of Pharmaceuticals. Advanced Materials. 2024;36(11). doi:10.1002/adma.202309164
BibTeX
@article{CarouSenra2024,
author = {Carou-Senra, Paola and Rodríguez-Pombo, Lucía and Awad, Atheer and Basit, Abdul W and Alvarez-Lorenzo, Carmen and Goyanes, Alvaro},
title = {Inkjet Printing of Pharmaceuticals},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {11},
doi = {10.1002/adma.202309164}
}
EUVIMED